Name | 6-(1,4-dihydroxy-3-methyl-6,7-dioxo-5-propan-2-ylnaphthalen-2-yl)-5,8-dihydroxy-7-methyl-1-propan-2-ylnaphthalene-2,3-dione |
---|---|
Synonyms |
apogossypolone
6,6',7,7'-tetrahydroxy-5,5'-diisopropyl-3,3'-dimethyl-2,2'-binaphthyl-1,1',4,4'-tetraone |
Description | Apogossypolone (ApoG2) is an orally active Bcl-2 family proteins inhibitor with Ki values of 35, 25 and 660 nM for Bcl-2, Mcl-1 and Bcl-XL, respectively. Apogossypolone shows antitumor activities, induces cell apoptosis[1] and autophagy[2]. Apogossypolone also has antifungal activity[3]. |
---|---|
Related Catalog | |
Target |
Mcl-1:25 nM (Ki) Bcl-2:35 nM (Ki) Bcl-xL:660 nM (Ki) |
In Vitro | Apogossypolone (ApoG2) shows improved stability under stressed conditions[1]. Apogossypolone (0-1 µM, 72 or 96 h) inhibits WSU-DLCL2 cells growth in a dose-dependent manner[1]. Apogossypolone (0-5 µM, 24 or 48 h) interferes with the formation of heterodimers between anti-apoptotic and pro-apoptotic Bcl-2 family members, and leads to cleavage of caspase-3, caspase-9 and PARP[1]. Apogossypolone (0-8 µM, 0-72 h) induces apoptotic WSU-DLCL2 cell death in a time- and dose-dependent manner[1]. Apogossypolone (0-10 µM, 0-24 h) induces autophagy and promotes ROS generation in HCC cells[2]. Cell Proliferation Assay[1] Cell Line: WSU-DLCL2 Concentration: 250, 350, 500 and 1000 nM Incubation Time: 96 h for cell counting, 72 h for MTT Result: Inhibited growth in a dose-dependent manner. The 50% growth inhibition concentration (IC50) was approximately 350 nM. Western Blot Analysis[1] Cell Line: WSU-DLCL2 Concentration: 0.35, 0.5, 1 and 5 µM Incubation Time: 24 or 48 h Result: Blocked the formation of heterodimers between Bcl-XL and Bim in a concentration-dependent manner. Resulted in the activation of cleavages of caspase-3, caspase-9 and PARP. Apoptosis Analysis[1] Cell Line: WSU-DLCL2 Concentration: 0, 1, 2, 4 and 8 µM Incubation Time: 24, 48 and 72 h Result: Induced cell apoptosis in a time- and dose-dependent manner. Cell Autophagy Assay[2] Cell Line: HepG2 and Hep3B Concentration: 1.25, 2.5, 5 and 10 µM Incubation Time: 6, 12, 18 and 24 h Result: Induced LC3 (Light chain 3)-II conversion in a dose- and time-dependent manner. |
In Vivo | Apogossypolone (ApoG2) (120 mg/kg; i.v. or p.o.; once a day for 5 days) effectively inhibits growth of diffuse large cell lymphoma cells without toxicity[1]. Animal Model: Four-week-old female ICR-SCID mice, each mouse received 107 WSU-DLCL2 cells (in serum-free RPMI 1640) subcutaneously (sc) in each flank area[1] Dosage: 120 mg/kg Administration: Intravenous or administration per day for five days Result: Inhibited the growth of WSU-DLCL2 and significantly decreased the tumor weight. Animal Model: Non-tumor-bearing SCID mice[1] Dosage: 160 mg/kg Administration: Intravenous or administration per day for five days Result: Was well tolerated in mice up to 800 mg/kg. Displayed no gross signs of toxicity. |
References |
Molecular Formula | C28H26O8 |
---|---|
Molecular Weight | 490.50 |
Exact Mass | 490.16300 |
PSA | 149.20000 |
LogP | 4.84700 |
Storage condition | -20℃ |